DEA Judge Pauses Broader Marijuana Rescheduling — Cannabis Stocks Slide
A DEA judge paused the broader marijuana Schedule III hearing after a GAO report found gaps in federal drug reviews. Medical cannabis already moved in April.
/ 6 items
#CRON↓
Cannabis Stocks Drop After Early Surge on Limited US Marijuana Rescheduling Move
Cannabis stocks fell after hype faded: US reform helps medical marijuana only, not full market, so investors took profits.
Trump Administration Set to Reclassify Marijuana This Week
The Trump administration is expected to reclassify marijuana from Schedule I to Schedule III as soon as this week, easing research barriers after months of delay.
Trump Orders Move to Reschedule Cannabis, Easing Medical and Business Rules
President Trump signs an executive order to shift cannabis to Schedule III, potentially expanding medical use, research, and business opportunities nationwide.
Trump Signals Major Shift on U.S. Cannabis Policy as Pot Stocks Surge
Cannabis stocks jumped after reports that President Trump may push to reclassify marijuana to Schedule III, easing restrictions and boosting industry prospects.
Cronos Group Expands into Netherlands with CanAdelaar Acquisition
Cronos Group acquires CanAdelaar, the leading cannabis company in the Netherlands’ Wietexperiment, strengthening its European footprint and borderless product strategy.